Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Help & FAQ
Home
Profiles
Research units
Core Facilities
Publications
Search by expertise, name or affiliation
Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes
Sai C. Chan, Jon M. Hanifin
Dermatology
Research output
:
Contribution to journal
›
Article
›
peer-review
63
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone
69%
Atopic Dermatitis
17%
Enzymes
13%
In Vitro Techniques
7%
Inflammation
4%
Isoenzymes
8%
Leukocytes
52%
Lymphocytes
11%
Monocytes
13%
Mononuclear Leukocytes
45%
nitraquazone
54%
Phosphodiesterase Inhibitors
20%
Phosphoric Diester Hydrolases
76%
Protein Isoforms
53%
Rolipram
11%
Skin
4%
T-Lymphocytes
10%
Theophylline
9%
Therapeutics
1%
Type 4 Cyclic Nucleotide Phosphodiesterase
12%
Xanthine
10%
Chemical Compounds
Adenosine
63%
EC 3.1.4.* (Phosphoric Diester Hydrolase) Inhibitor
100%
Methylxanthine
51%
Pharmacological Metabolism
25%
Rate Constant
21%
Rolipram
54%
Theophylline
39%
Social Sciences
discrimination
9%
Group
3%
management
6%
regulation
7%